Japan Radiation Oncology Market Size & Outlook, 2026-2033

The radiation oncology market in Japan is expected to reach a projected revenue of US$ 1,505.6 million by 2033. A compound annual growth rate of 9.7% is expected of Japan radiation oncology market from 2026 to 2033.
Revenue, 2025 (US$M)
$720.0
Forecast, 2033 (US$M)
$1,505.6
CAGR, 2026 - 2033
9.7%
Report Coverage
Japan

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan radiation oncology market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Japan radiation oncology market highlights

  • The Japan radiation oncology market generated a revenue of USD 720.0 million in 2025 and is expected to reach USD 1,505.6 million by 2033.
  • The Japan market is expected to grow at a CAGR of 9.7% from 2026 to 2033.
  • In terms of segment, external beam radiation therapy (ebrt) was the largest revenue generating treatment type in 2025.
  • Systemic Targeted Radiation Therapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.


Radiation oncology market data book summary

Market revenue in 2025USD 720.0 million
Market revenue in 2033USD 1,505.6 million
Growth rate9.7% (CAGR from 2026 to 2033)
Largest segmentExternal beam radiation therapy (ebrt)
Fastest growing segmentSystemic Targeted Radiation Therapy
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationExternal Beam Radiation Therapy (EBRT), Internal Beam Radiation Therapy, Systemic Targeted Radiation Therapy
Key market players worldwideSiemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay


Other key industry trends

  • In terms of revenue, Japan accounted for 5.1% of the global radiation oncology market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China radiation oncology market is projected to lead the regional market in terms of revenue in 2033.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 907.2 million by 2033.

External beam radiation therapy (ebrt) was the largest segment with a revenue share of 78.43% in 2025. Horizon Databook has segmented the Japan radiation oncology market based on external beam radiation therapy (ebrt), internal beam radiation therapy, systemic targeted radiation therapy covering the revenue growth of each sub-segment from 2021 to 2033.


Cancer is the most common cause of death in Japan. Its aging population is one of the major factors responsible for increase in prevalence of cancer. Lung cancer is the leading cause of cancer-related deaths in Japan, followed by stomach and colorectal cancers. 

According to WHO, in 2018, Japan had an age-standardized cancer rate of 248.0 per 100,000 people. Moreover, a total of 883,395 new cases of cancer were recorded in Japan. Each year, approximately 13,000 patients undergo radiation therapy in Japan. 

The Japanese Foundation for Cancer Research conducts radiation therapy to treat 1,700 patients per year. Geographic expansion of key players to increase their market share and introduction of novel technologies in the country are expected to boost market growth.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiation Oncology Market Scope

Radiation oncology market segmentation & scope

Radiation Oncology Market Companies

Name Profile # Employees HQ Website
ViewRay View profile 251-500 Oakwood, Ohio, United States, North America http://www.viewray.com
Curium Pharma View profile 1001-5000 Paris, Ile-de-France, France, Europe https://www.curiumpharma.com/contact/
Ntp Radioisotopes View profile 251-500 Brits, NA - South Africa, South Africa, Africa https://www.ntp.co.za/
Nordion View profile 251-500 Kanata, Ontario, Canada, North America http://nordion.com
MeVis Medical Solutions AG View profile 101-250 Bremen, Bremen, Germany, Europe http://www.mevis.de/
IBA RadioPharma Solutions View profile 1001-5000 Louvain-la-neuve, Vlaams-Brabant, Belgium, Europe https://www.iba-radiopharmasolutions.com/
Accuray Inc View profile 1024 1240 Deming Way, Madison, WI, United States, 53717 https://www.accuray.com
IsoRay View profile 51-100 Richland, Washington, United States, North America https://isoray.com/
Elekta AB ADR View profile 4584 Kungstensgatan 18, Box 7593, Stockholm, Sweden, SE-103 93 https://www.elekta.com
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com

Japan radiation oncology market size, by treatment type, 2021-2033 (US$M)

Japan Radiation Oncology Market Outlook Share, 2025 & 2033 (US$M)

Japan radiation oncology market size, by treatment type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online